SUPPRELIN LA
NDC 67979-002, histrelin acetate, implant, from Endo USA, Inc..
- Product NDC
- 67979-002
- Status
- Listed
- Labeler
- Endo USA, Inc.
- Dosage form
- IMPLANT
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022058
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/67979-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- HISTRELIN ACETATE50 mg/1
Pharmacologic classes
Gonadotropin Releasing Hormone Receptor Agonist [EPC]; Gonadotropin Releasing Hormone Receptor Agonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 67979-002-01 | 67979000201 | 1 VIAL, GLASS in 1 CARTON (67979-002-01) / 1 IMPLANT in 1 VIAL, GLASS |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/d8fb000e-3cc9-4803-b71d-2cc597661977Medicare Part B payment limits (ASP)
GET /v1/drugs/asp?ndc=67979-002
Use it
Look up 67979-002 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/67979-002 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 67979-002. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.